Medtronic price target lowered to $77 from $82 at Wells Fargo

Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Medtronic to $77 from $82 and keeps an Equal Weight rating on the shares. The analyst is updating his 2024 and forward EPS forecast for Medtronic, as he corrects for the company’s expected FX impact on EPS.